Analysis of aclarubicin-induced cell death in human fibroblasts

Cell Biology International

Volumn 31, Issue 9, 2007, Pages 1049-1056

  Kania, K ^a   Matlawska Wasowska K ^a   Osiecka, R ^a   Jozwiak Z ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Aclarubicin; Apoptosis; Caspase 3; Down's syndrome; Fibroblasts; Necrosis

Indexed keywords

ACETYLASPARTYLGLUTAMYLVALYLASPARTALDEHYDE; ACLARUBICIN; ACRIDINE ORANGE; ALDEHYDE DERIVATIVE; AMINO ACID DERIVATIVE; CASPASE 3; CASPASE 3 INHIBITOR; DNA FRAGMENT; ETHIDIUM BROMIDE; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL DEATH; CELL POPULATION; CELL TYPE; COMET ASSAY; CONTROLLED STUDY; DNA DEGRADATION; DNA STRAND BREAKAGE; DRUG MECHANISM; ENZYME ACTIVITY; FIBROBLAST; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; TRISOMY;

ACLARUBICIN; ANTINEOPLASTIC AGENTS; CASPASE 3; CELL DEATH; CELL PROLIFERATION; COMET ASSAY; DNA FRAGMENTATION; DOWN SYNDROME; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; KINETICS; NECROSIS; NUCLEOSOMES;

EID: 34249299748     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.03.024     Document Type: Article

References (38)

1. Abt G., Vaghef H., Gebhart E., Dahlgren C.V., and Hellman B. The role of N-acetylcysteine as a putative radioprotective agent on X-ray-induced DNA damage as evaluated by alkaline single-cell gel electrophoresis. Mutat Res 384 (1997) 55-64
2. Anderson A.J., Stoltzner S., Lai F., Su J., and Nixon R.A. Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL. Neurobiol Aging 21 (2000) 511-524
3. Atsumi T., Tonosaki K., and Fujisawa S. Induction of early apoptosis and ROS-generation activity in human gingival fibroblasts (HGF) and human submandibular gland carcinoma (HSG) cells treated with curcumin. Arch Oral Biol 51 (2006) 913-921
4. Busciglio J., and Yanker B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378 (1995) 776-779
5. Chandna S. Single-cell gel electrophoresis assay monitors precise kinetics of DNA fragmentation induced during programmed cell death. Cytometry 61 part A (2004) 127-133
6. Chen J., Chai M., Chen H., Zhao S., and Song J. Regulation of phospholipase D activity and ceramide production in daunorubicin- induced apoptosis in A-431 cells. Biochim Biophys Acta 1488 (2000) 219-232
7. Choucroun P., Gillet D., Dorange G., Sawicki B., and Dewitte J.D. Comet assay and early apoptosis. Mutat Res 478 (2001) 89-96
8. Collins A.R. The comet assay. Principles, applications, and limitations. Methods Mol Biol 203 (2002) 163-177
9. Dartsch D.C., Schaefer A., Boldt S., Kolch W., and Marquardt H. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis. Apoptosis 7 (2002) 537-548
10. Darzynkiewicz Z., Juan G., Li X., Gorczyca W., Murakami T., and Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27 (1997) 1-20
11. Fadeel B., Orrenius S., and Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony. Biochem Biophys Res Commun 266 (1999) 699-717
12. Gervasoni Jr. J.E., Hindenburg A.A., Vezeridis M.P., Schulze S., Wanebo H.J., and Mehta S. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis. Anticancer Res 24 (2004) 2617-2626
13. Godard T., Deslandes E., Lebailly P., Vigreux C., Sichel F., Poul J.M., et al. Early detection of staurosporine-induced apoptosis by comet and annexin V assays. Histochem Cell Biol 112 (1999) 155-161
14. Gulesserian T., Engidawork E., Yoo B.C., Cairns N., and Lubec G. Alteration of caspases and other apoptosis regulatory proteins in Down syndrome. J Neural Transm 61 (2001) 163-179
15. Hanada M., Noguchi T., and Yamoka T. Amrubicin induces apoptosis in human tumor cells mediated by the activation of caspase-3/7 preceding a loss of mitochondrial membrane potential. Cancer Sci 97 (2006) 1396-1403
16. Head E., Lott J.T., Cribbs D.H., Cotman C.W., and Rohn T.T. β-Amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome. Neurosci Lett 330 (2002) 99-103
17. Huigsloot M., Tijdens I.B., Mulder G.J., and van de Water B. Differential regulation of phosphatidylserine externalization and DNA fragmentation by caspases in anticancer drug-induced apoptosis of rat mammary adenocarcinoma MTLn3 cells. Biochem Pharmacol 62 (2001) 1087-1097
18. Iselius L., Jacobs P., and Morton N. Leukaemia and transient leukaemia in Down syndrome. Human Genet 85 (1990) 477-485
19. Kania K., Dragojew S., and Jóźwiak Z. Morphological and biochemical changes in human fibroblast lines induced by anthracyclines during apoptosis. Cell Mol Biol Lett 8 (2003) 121-126
20. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
21. Koceva-Chyła A., Je{ogonek}drzejczak M., Skierski J., Kania K., and Jóźwiak Z. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation. Apoptosis 10 (2005) 1497-1514
22. Końca K., Lankoff A., Banasik A., Lisowska H., Kuszewski T., Góźdź S., et al. A cross platform public domain PC image analysis program for the comet assay. Mutat Res 534 (2003) 15-20
23. Kosmider B., Zyner E., Osiecka R., and Ochocki J. Induction of apoptosis and necrosis in A 549 cells by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat Res 563 (2004) 61-70
24. Lavrik I.N., Golks A., and Krammer P.H. Caspases: pharmacological manipulation of cell death. J Clin Invest 115 (2005) 2665-2672
25. Majno G., and Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146 (1995) 3-15
26. Mashima T., and Tsuruo T. Defects the apoptotic pathway as therapeutic target against cancer. Drug Resist Update 8 (2005) 339-343
27. Müller I., Jenner A., Bruchelt G., Niethammer D., and Halliwell B. Effect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage. Biochem Biophys Res Commun 230 (1997) 254-257
28. 16) 65 Dn mouse, a murine model for human Down's syndrome. J Immunol 163 (1999) 5399-5410
29. Pelsman A., Hoyo-Vadillo C., Gudasheva T.A., Seredenin S.B., Ostrovskaya R.U., and Busciglio J. GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. Int J Devl Neuroscience 21 (2003) 117-124
30. Przybylska M., Koceva-Chyła A., Rózga B., and Jóźwiak Z. Cytotoxicity of daunorubicin in trisomic (+21) human fibroblasts: relation to drug uptake and cell membrane fluidity. Cell Biol Int 25 (2001) 157-170
31. Ravindranath Y. Down syndrome and leukemia: new insights into the epidemiology, pathogenesis and treatment. Pediatr Blood Cancer 44 (2005) 1-7
32. Saraste A., and Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45 (2000) 528-537
33. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175 (1988) 184-191
34. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
35. Tsang W.P., Chau S.P., Kong S.K., Fung K.P., and Kwok T.T. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci 73 (2003) 2047-2058
36. Turnbull K.J., Brown B.L., and Dobson P.R. Caspase-3-like activity is necessary but not sufficient for daunorubicin-induced apoptosis in Jurkat human lymphoblastic leukemia cells. Leukemia 13 (1999) 1056-1061
37. Wilkins R.C., Kutzer B.C., Truong M., Sanchez-Dardon J., and Mclean J.R. Analysis of radiation-induced apoptosis in human lymphocytes: flow cytometry using Annexin V and propidium iodide versus the neutral comet assay. Cytometry 48 (2002) 14-19
38. Zatorska A., and Jóźwiak Z. Involvement of glutathione and glutathione-related enzymes in the protection of normal and trisomic human fibroblasts against daunorubicin. Cell Biol Int 26 (2002) 383-391